| 000 | 01626 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250517070010.0 | ||
| 264 | 0 | _c20160727 | |
| 008 | 201607s 0 0 eng d | ||
| 022 | _a1715-3360 | ||
| 024 | 7 |
_a10.1016/j.jcjo.2015.08.013 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aIlyas, Faizah | |
| 245 | 0 | 0 |
_aIntraocular pressure rise in the course of peginterferon alpha-2a, ribavirin, and boceprevir therapy for hepatitis C. _h[electronic resource] |
| 260 |
_bCanadian journal of ophthalmology. Journal canadien d'ophtalmologie _cDec 2015 |
||
| 300 |
_ae112-4 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Letter | ||
| 650 | 0 | 4 |
_aAntiviral Agents _xadverse effects |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGlaucoma, Open-Angle _xcomplications |
| 650 | 0 | 4 | _aGonioscopy |
| 650 | 0 | 4 |
_aHepatitis C, Chronic _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInterferon-alpha _xadverse effects |
| 650 | 0 | 4 |
_aIntraocular Pressure _xdrug effects |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPolyethylene Glycols _xadverse effects |
| 650 | 0 | 4 |
_aProline _xadverse effects |
| 650 | 0 | 4 |
_aRecombinant Proteins _xadverse effects |
| 650 | 0 | 4 |
_aRibavirin _xadverse effects |
| 650 | 0 | 4 | _aTonometry, Ocular |
| 650 | 0 | 4 | _aViral Load |
| 650 | 0 | 4 | _aVisual Fields |
| 700 | 1 | _aSingh, Harmanjit | |
| 700 | 1 | _aAnand, Navin | |
| 700 | 1 | _aAhmed, Iqbal Ike K | |
| 773 | 0 |
_tCanadian journal of ophthalmology. Journal canadien d'ophtalmologie _gvol. 50 _gno. 6 _gp. e112-4 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.jcjo.2015.08.013 _zAvailable from publisher's website |
| 999 |
_c25526980 _d25526980 |
||